-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Notice on the Public Solicitation of Opinions on the Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials
Release date: 20221008
To further guide the assessment of the potential for drug-induced liver injury in clinical trials of drugs, to ensure the safety of subjects, and to obtain safety information to assess the risk characteristics
We sincerely welcome all sectors of the community to put forward valuable comments and suggestions on the draft for comments, and timely feedback to us for follow-up improvement
Please send your feedback to the email address of the following contact:
Contact: Chen Ying, He Chunli
Contact: cheny@cde.
Thank you for your participation and great support
Centre for Drug Evaluation
October 8, 2022
Related Attachments
serial number | The attachment name |
---|---|
1 | The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials (Draft for Solicitation of Comments) . |
2 | The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials . pdf drafted instructions |
3 | The Guiding Principles for the Identification, Management and Evaluation of Drug-induced Liver Injury in Clinical Trials . docx for Solicitation of Comments |